Overview

Clinical Study of Efficacy and Safety of Chung A Won in Women's Patients With Osteoporosis

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
A randomized, single center, double blind, parallel, placebo-controlled, clinical study of efficacy and safety of Chung A Won and placebo for 24 weeks three times a day on the improvement of osteoporosis and symptoms in Women's older than 50 patients with osteoporosis.
Phase:
Phase 2
Details
Lead Sponsor:
Korea Health Industry Development Institute